Health Interests

New Global Report Finds Majority of People at High Risk of Stroke Not Being Screened for Common Risk Factors

September 21, 2017

PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–New research released today by The Economist Intelligence Unit (EIU), a division of The Economist and a leader in global business intelligence, revealed that on average, more than 75 percent of people aged 65 and older worldwide are not being screened for atrial fibrillation (AF) and other common stroke risk […]

Demand for genetic testing drives growth for award winning Elucigene diagnostics

September 18, 2017

Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics. The Manchester-based company has been selected as the winner of the Venture-backed Management Team 2017 award for the Northwest in the prestigious British Private Equity & Venture Capital Association […]

Lysogene Launches World Class Clinical Advisory Board

September 13, 2017

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases, today announced the appointments of leading experts to its newly formed Clinical Advisory Board (CAB). The CAB will provide strategic advice to Lysogene as it continues to advance its clinical […]

HHS spurs new antibiotic development for biodefense and common infections

September 11, 2017

To combat potentially deadly Clostridium difficile infections that can occur in patients being treated for bacterial infections including anthrax, tularemia and other biothreats, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is partnering with Summit Therapeutics on late-stage development of a new antibiotic. “To save […]

New Certara Paper Shows How Viral Kinetic Modeling Increases Influenza Knowledge and Advances Drug Development

September 7, 2017

Paper highlights benefits of combining different types of mathematical modeling to maximize use of all available pre-clinical, clinical and epidemiological data Certara®, the global leader in model-informed drug development and regulatory science, today announced that its comprehensive influenza viral kinetic modeling review has just been published in Current Pharmacology Reports. As the number of drug-resistant […]

New AstraZeneca, Amgen drug looks strong rival in severe asthma

September 7, 2017

A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than existing medicines like GlaxoSmithKline’s Nucala.   Findings from a mid-stage clinical trial involving 584 patients showed on Wednesday the experimental drug tezepelumab reduced the annual rate of serious asthma attacks, known […]

The New Reality: Maximizing Value in Rare Disease Launches

September 7, 2017

The rare disease landscape is changing: with assets being granted expedited review, launch is no longer a fixed point in time, and research and development (R&D), medical affairs, and commercial teams need to collaborate early in the process to reach critical consensus on where to focus, when to engage key health care provider (HCP) stakeholders, […]

Mercy Medical Center Earns Joint Commission Certification in Uterine & Ovarian Cancer

September 6, 2017

(Baltimore, MD) – Mercy Medical Center has achieved initial certification in Uterine and Ovarian Cancer Care from The Joint Commission, Disease-Specific Care Certification process. Mercy is the first hospital in Maryland to achieve Uterine and Ovarian Cancer care certification, and is only one of five institutions nationwide to be so honored. Mercy’s programs in the […]

marcus evans to Host the 2nd Annual Innovation Excellence for Life Sciences Conference on November 29-30, 2017 in Boston, MA

September 5, 2017

marcus evans will host the 2nd Annual Innovation Excellence for Life Sciences Conference on November 29-30, 2017 in Boston, MA. By attending this exclusive event, delegates will receive practical knowledge and tangible insights from leading innovation, R&D, corporate development and strategic alliance professionals on how to institute internal frameworks that foster cross-lateral participation in innovation, […]

Immuno-Oncology 360° Summit Confirms Program Line-up for February 7-9, 2018

August 30, 2017

The 4th annual IO360°, organized by The Conference Forum, presents a three-day agenda providing the most up-to-date research, data and progress to help IO stakeholders fight a wider range of cancers. Immuno-Oncology 360° ‘IO360° continues to help the immuno-oncology community stay at the forefront of the most relevant research and developments from key industry leaders, […]

FEEDBACK